UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

Annals of the rheumatic diseases, 2023-01, Vol.82 (1), p.130-141

2023

Volltextzugriff (PDF)

Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

Annals of the rheumatic diseases, 2023-01, Vol.82 (1), p.142-152

2023

Volltextzugriff (PDF)

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Annals of the rheumatic diseases, 2021-11, Vol.80 (11), p.1436-1444

2021

Volltextzugriff (PDF)

Depression in ankylosing spondylitis and the role of disease-related and contextual factors: a cross-sectional study

Arthritis research & therapy, 2019-10, Vol.21 (1), p.215-215, Article 215

2019

Volltextzugriff (PDF)

Costs of disease: The perspective matters

International journal of rheumatic diseases, 2021-03, Vol.24 (3), p.293-296

2021

Volltextzugriff (PDF)

Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Ramiro et al

Annals of the rheumatic diseases, 2023-03, p.ard-2023-223937

2023

Volltextzugriff (PDF)

2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work

Annals of the rheumatic diseases, 2023-01, Vol.82 (1), p.57-64

2023

Volltextzugriff (PDF)

Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands

Clinical rheumatology, 2020-10, Vol.39 (10), p.2889-2897

2020

Volltextzugriff (PDF)

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Arthritis research & therapy, 2020-09, Vol.22 (1), p.1-225, Article 225

2020

Volltextzugriff (PDF)

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness‐to‐Pay Approach

Arthritis care & research (2010), 2018-04, Vol.70 (4), p.608-616

2018

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registry

Rheumatic & musculoskeletal diseases open, 2022-09, Vol.8 (2), p.e002447

2022

Volltextzugriff (PDF)

Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net)

Rheumatic & musculoskeletal diseases open, 2019-04, Vol.5 (1), p.e000860-e000860

2019

Volltextzugriff (PDF)

Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation

Rheumatic & musculoskeletal diseases open, 2023-01, Vol.9 (1), p.e002903

2023

Volltextzugriff (PDF)

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study

Rheumatic & musculoskeletal diseases open, 2018-11, Vol.4 (2), p.e000766-e000766

2018

Volltextzugriff (PDF)

Go or no-go for treat-to-target in axial spondyloarthritis?

Current opinion in rheumatology, 2023-07, Vol.35 (4), p.243-248

2023

Volltextzugriff (PDF)

To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question

Best practice & research. Clinical rheumatology, 2023-09, Vol.37 (3), p.101869-101869, Article 101869

2023

Volltextzugriff (PDF)

Barriers and facilitators to application of treat-to-target management in psoriatic arthritis and axial spondyloarthritis in practice: A systematic literature review

Seminars in arthritis and rheumatism, 2024-12, Vol.69, p.152546, Article 152546

2024

Volltextzugriff (PDF)

Tapering or discontinuation of biological disease-modifying antirheumatic drugs in axial spondyloarthritis: A review of the literature and discussion on current practice

Joint, bone, spine : revue du rhumatisme, 2023-01, Vol.90 (1), p.105482-105482, Article 105482

2023

Volltextzugriff (PDF)

Factors Associated With Residual Disease in Axial Spondyloarthritis: Results From a Clinical Practice Registry

Journal of rheumatology, 2023-11, Vol.50 (11), p.1430-1438

2023

Volltextzugriff (PDF)

Treat-to-target in axial spondyloarthritis: an observational study in daily practice

Rheumatology (Oxford, England), 2022-04, Vol.61 (4), p.1396-1407

2022

Volltextzugriff (PDF)

Depression in ankylosing spondylitis and the role of disease-related and contextual factors: A structural equation modeling approach

Journal of psychosomatic research, 2019-06, Vol.121, p.130-130

2019

Volltextzugriff (PDF)

Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study

Rheumatology (Oxford, England), 2016-03, Vol.55 (3), p.419-428

2016

Volltextzugriff (PDF)

Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice

Rheumatology (Oxford, England), 2023-12

2023

Volltextzugriff (PDF)

Décroissance ou arrêt des traitements de fond biologiques dans la spondyloarthrite axiale : revue de la littérature

Revue du rhumatisme (Ed. française : 1993), 2023-05, Vol.90 (3), p.291-304

2023

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(42)

Publikationsform

Sprache

Englisch
(58)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(44)
Rheumatology
(30)
Humans
(26)
Female
(13)
Male
(13)
Ankylosing Spondylitis
(12)
Arthritis
(12)
Axial Spondyloarthritis
(11)
Middle Aged
(11)
Patients
(11)
Aged
(9)
Spondyloarthritis
(9)
Epidemiology
(8)
Adult
(7)
Biomarkers
(7)
Inflammatory Diseases
(7)
Rheumatic Diseases
(7)
Antirheumatic Agents - Therapeutic Use
(6)
Quality Of Life
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Depression in ankylosing spondylitis and the role of disease-related and contextual factors: a cross-sectional study

Costs of disease: The perspective matters

Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Ramiro et al

2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work

Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness‐to‐Pay Approach

Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registry

Development, usability and acceptability of an integrated eHealth system for spondyloarthritis in the Netherlands (SpA-Net)

Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study

Go or no-go for treat-to-target in axial spondyloarthritis?

To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question

Barriers and facilitators to application of treat-to-target management in psoriatic arthritis and axial spondyloarthritis in practice: A systematic literature review

Tapering or discontinuation of biological disease-modifying antirheumatic drugs in axial spondyloarthritis: A review of the literature and discussion on current practice

Factors Associated With Residual Disease in Axial Spondyloarthritis: Results From a Clinical Practice Registry

Treat-to-target in axial spondyloarthritis: an observational study in daily practice

Depression in ankylosing spondylitis and the role of disease-related and contextual factors: A structural equation modeling approach

Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study

Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice

Décroissance ou arrêt des traitements de fond biologiques dans la spondyloarthrite axiale : revue de la littérature

Suchergebnisse filtern